Rekombinanter MS4A1 (Obinutuzumab Biosimilar) Antikörper

Produktnummer ABIN7795118

Dieser Maus Monoklonal Antikörper erkennt spezifisch MS4A1 (Obinutuzumab Biosimilar) in FACS und in vivo. Er zeigt eine Reaktivität gegenüber Human.

Kurzübersicht für Rekombinanter MS4A1 (Obinutuzumab Biosimilar) Antikörper (ABIN7795118)

Target: MS4A1 (Obinutuzumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser MS4A1 (Obinutuzumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), In vivo Studies (in vivo)

Güteklasse: Research Grade

Produktdetails anti-MS4A1 (Obinutuzumab Biosimilar) Antikörper

Expressionssystem: Mammalian cells

Verwendungszweck: Obinutuzumab Biosimilar, CD20 Monoclonal Antibody

Produktmerkmale: Obinutuzumab Biosimilar uses the same protein sequences as the therapeutic antibody obinutuzumab. Obinutuzumab is an antineoplastic CD20 antibody used to treat untreated chronic lymphocytic leukemia in combination with chlorambucil. In contrast to rituximab, which is a classic type I CD20 antibody, obinutuzumab binds to type II CD20 antibodies. This allows obinutuzumab to have a much higher induction of antibody-dependant cytotoxicity and a higher direct cytotoxic effect than the classic CD20 antibodies.

Aufreinigung: Protein A or G affinity column

Reinheit: >95 % by reducing SDS-PAGE

Endotoxin-Niveau: < 1 EU per 1 mg of the protein by the LAL method

Immunogen: Human CD20

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: > 3 mg/mL

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Details zu MS4A1 (Obinutuzumab Biosimilar)

Target: MS4A1 (Obinutuzumab Biosimilar)

Andere Bezeichnung: Obinutuzumab Biosimilar

Substanzklasse: Biosimilar